NASDAQ:ADMA

Adma Biologics Stock News

*Your capital is at risk

$8.69

+0.120 (+1.40%)

At Close: Jun 23, 2026

ADMA Biologics Investors Prepare For RI-002 PDUFA

09:09am, Monday, 01'st Apr 2019

Back on December 19th, ADMA Biologics (ADMA) received a complete response letter "CRL" from the FDA concerning their PAS for BIVIGAM.

featured in The Global Fintech Index 2020 as the top Fintech company of the country.